Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett […]

Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced that the Company's management team will

Profusa Adds Leading Greek Vascular Surgeon to Customer Base GlobeNewswire January 08, 2026 Dr. Theodosios Bisdas is a renowned vascular surgeon and Head of Clinic of Vascular Surgery at the Athens Medical Center BERKELEY, Calif, Jan. 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company

Midland, in Partnership with Rio Tinto Exploration Canada, Intersects New Lithium and Cesium Bearing Pegmatites During the 2025 Drilling Program on the Galinee Project GlobeNewswire January 08, 2026 MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Rio Tinto Exploration Canada Inc. (“RTEC“), is pleased to announce the

GURU Organic Energy to Report Fourth Quarter and Fiscal Year 2025 Results GlobeNewswire January 08, 2026 MONTRÉAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company“), Canada's leading organic energy drink brand1, will report its financial results for the fourth quarter and fiscal year ended October 31, 2025

Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 08, 2026 Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) — Enovis(TM) Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 44th Annual J.P. Morgan Healthcare Conference with a presentation scheduled

Beneficient Enters into $3 Million GP Primary Capital Transaction GlobeNewswire January 08, 2026 DALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the

Public Affairs, Reputation and Issues Management Expert Joshua Baca Joins FTI Consulting GlobeNewswire January 08, 2026 WASHINGTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joshua Baca as a Senior Managing Director. Mr. Baca, who is based in Washington, D.C., joins FTI Consulting's Strategic Communications segment with

AGM Group Announces Strategic Memorandum of Understanding with Amber Premium in Building RWA Tokenization Initiatives GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today

Dragonfly Energy Issues Year-End CEO Letter to Shareholders GlobeNewswire January 08, 2026 RENO, Nev., Jan. 08, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage, today issued a Year-End Letter to Shareholders from its Chief Executive Officer and President, Dr. Denis Phares. Dear